When it comes to HIV prevention, each new development always comes with a BUT …… and in most cases, its inevitable the cost factor, which in turn will determine if everyone will be able to access it on their health insurance. Regardless, at this stage, we should congratulate GILEAD Sciences for their breakthrough drug Yeztugo…